ADALIMUMAB FOSIMDESONIDE
UNII FWC6IWT3EH

Substance Identification & Data

This profile provides standardized clinical and technical data for Adalimumab Fosimdesonide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FWC6IWT3EH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2402772-93-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FWC6IWT3EH

CAS Registry Number

2402772-93-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ADALIMUMAB FOSIMDESONIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190447

National Cancer Institute reference terminology for clinical and research data.

INN ID

11661

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-233

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Adalimumab Fosimdesonide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ADALIMUMAB FOSIMDESONIDE

Common Names & Synonyms

ABBV 154 [WHO-DD]

ADALIMUMAB FOSIMDESONIDE [INN]

ADALIMUMAB FOSIMDESONIDE [USAN]

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), COMPLEX WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER, 214'',214''',224,224'-TETRAKIS(THIOETHER) WITH N-(2-MERCAPTOACETYL)GLYCYL-N-(3-((4-((R)-(((11.BETA.,16.ALPHA.)-11-HYDROXY-3,20-DIOXO-21-(PHOSPHONOOXY)PREGNA-1,4-DIENE-16,17-DIYL)BIS(OXY))METHYL)PHENYL)METHYL)PHENYL)-L-.ALPHA.-GLUTAMINE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)), HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED TO A DERIVATIVE OF THE GLUCOCORTICOID RECEPTOR MODULATOR (GRM) DESONIDE (24)(12) VIA A (CYSTEIN-S-YL)ACETYL-GLY-GLU LINK

Technical Codes

ABBV154

ABBV-154

External Clinical & Regulatory Resources

Previous UNIIFWA9E3VB3K

Next UNIIFWC7ZK4SY7